Targeting STING to generate therapeutic anti-tumor immunity is a research paper published in Cancer Cell (2025). On theSindex it has a DataRank of 0. It has been cited 16 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
National Institutes of Health National Cancer Institute
Grant: R01CA190294
National Institutes of Health National Cancer Institute
Grant: P50CA265826
NCI NIH HHS
Grant: R01 CA190394
National Institutes of Health
Parker Institute for Cancer Immunotherapy
FWCI
7.97
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals